The Journal of Neuroscience, October 22, 2008, 28(43):10943-10951; doi:10.1523/JNEUROSCI.3594-08.2008
Previous Article | Next Article 
Cellular/Molecular
Analgesic
-Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation
Brid Callaghan,1
Alison Haythornthwaite,1
Géza Berecki,1
Richard J. Clark,2
David J. Craik,2 and
David J. Adams1
1Queensland Brain Institute and School of Biomedical Sciences, and 2Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
Correspondence should be addressed to Dr. David J. Adams, Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia. Email: dadams{at}uq.edu.au
-Conotoxins Vc1.1 and Rg1A are peptides from the venom of marine Conus snails that are currently in development as a treatment for neuropathic pain. Here we report that the
9
10 nicotinic acetylcholine receptor-selective conotoxins Vc1.1 and Rg1A potently and selectively inhibit high-voltage-activated (HVA) calcium channel currents in dissociated DRG neurons in a concentration-dependent manner. The post-translationally modified peptides vc1a and [P6O]Vc1.1 were inactive, as were all other
-conotoxins tested. Vc1.1 inhibited the
-conotoxin-sensitive HVA currents in DRG neurons but not those recorded from Xenopus oocytes expressing CaV2.2, CaV2.1, CaV2.3, or CaV1.2 channels. Inhibition of HVA currents by Vc1.1 was not reversed by depolarizing prepulses but was abolished by pertussis toxin (PTX), intracellular GDPβS, or a selective inhibitor of pp60c-src tyrosine kinase. These data indicate that Vc1.1 does not interact with N-type calcium channels directly but inhibits them via a voltage-independent mechanism involving a PTX-sensitive, G-protein-coupled receptor. Preincubation with a variety of selective receptor antagonists demonstrated that only the GABAB receptor antagonists, [S-(R*,R*)][-3-[[1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxy propyl]([3,4]-cyclohexylmethyl) phosphinic acid hydrochloride (2S)-3[[(1S)-1-(3,4-dichlorophenyl)-ethyl]amino-2-hydroxypropyl](phenylmethyl) phosphinic acid and phaclofen, blocked the effect of Vc1.1 and Rg1A on Ca2+ channel currents. Together, the results identify CaV2.2 as a target of Vc1.1 and Rg1A, potentially mediating their analgesic actions. We propose a novel mechanism by which
-conotoxins Vc1.1 and Rg1A modulate native N-type (CaV2.2) Ca2+ channel currents, namely acting as agonists via G-protein-coupled GABAB receptors.
Key words: conotoxins; N-type calcium channel; dorsal root ganglion; GABAB receptor; G-protein; analgesia
Received July 23, 2008;
revised Aug. 30, 2008;
accepted Sept. 8, 2008.
Correspondence should be addressed to Dr. David J. Adams, Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia. Email: dadams{at}uq.edu.au
This article has been cited by other articles:

|
 |

|
 |
 
R. Halai, R. J. Clark, S. T. Nevin, J. E. Jensen, D. J. Adams, and D. J. Craik
Scanning Mutagenesis of {alpha}-Conotoxin Vc1.1 Reveals Residues Crucial for Activity at the {alpha}9{alpha}10 Nicotinic Acetylcholine Receptor
J. Biol. Chem.,
July 24, 2009;
284(30):
20275 - 20284.
[Abstract]
[Full Text]
[PDF]
|
 |
|